Efficacy of mindfulness-based interventions on psychological distress, hyperandrogenism, and metabolic profile in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials
Abstract
Polycystic ovary syndrome (PCOS) negatively impacts women's metabolic health, reproductive hormones, and psychological well-being. The aim of this study was to systematically evaluate the efficacy of mindfulness-based interventions (MBIs), such as yoga and mindfulness meditation, on anthropometric indices, metabolic profiles, reproductive hormones, and quality of life in women with PCOS. A systematic review and meta-analysis was conducted with 10 randomized controlled trials (RCTs) involving 356 participants, selected from databases including PubMed and Cochrane Library up to January 2025. Data were synthesized using Review Manager 5.3 to calculate mean differences (MDs) and standardized mean differences (SMDs). Women in the MBI groups showed significant reductions in BMI, body weight, abdominal circumference, and preliminary improvements in insulin resistance (HOMA-IR; based on two studies), alongside improvements in total testosterone levels and clinical hirsutism. Although generic depression and anxiety scores did not show significant differences, disease-specific quality of life improved significantly. MBIs show potential as metabolic and endocrine modulators and may offer benefits in insulin sensitivity, weight management, and hyperandrogenism beyond mere stress reduction for women with PCOS.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 356 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.